Dembitz, Vilma https://orcid.org/0000-0002-9463-253X
Lawson, Hannah
Burt, Richard
Natani, Sirisha
Philippe, Céline https://orcid.org/0000-0002-8546-3893
James, Sophie C.
Atkinson, Samantha
Durko, Jozef https://orcid.org/0000-0002-2395-8946
Wang, Lydia M.
Campos, Joana
Magee, Aoife M. S.
Woodley, Keith
Austin, Michael J. https://orcid.org/0000-0003-4218-0284
Rio-Machin, Ana https://orcid.org/0000-0001-6733-9752
Casado, Pedro https://orcid.org/0000-0002-4207-9349
Bewicke-Copley, Findlay https://orcid.org/0000-0003-1292-7965
Rodriguez Blanco, Giovanny https://orcid.org/0000-0002-7154-7244
Pereira-Martins, Diego
Oudejans, Lieve https://orcid.org/0000-0003-1110-8028
Boet, Emeline
von Kriegsheim, Alex
Schwaller, Juerg https://orcid.org/0000-0001-8616-0096
Finch, Andrew J. https://orcid.org/0000-0002-8065-4623
Patel, Bela https://orcid.org/0000-0002-1875-8974
Sarry, Jean-Emmanuel https://orcid.org/0000-0002-6704-2032
Tamburini, Jerome
Schuringa, Jan Jacob
Hazlehurst, Lori
Copland III, John A. https://orcid.org/0000-0001-5091-6242
Yuneva, Mariia
Peck, Barrie https://orcid.org/0000-0002-6687-8495
Cutillas, Pedro https://orcid.org/0000-0002-3426-2274
Fitzgibbon, Jude https://orcid.org/0000-0002-9069-1866
Rouault-Pierre, Kevin https://orcid.org/0000-0001-7671-7364
Kranc, Kamil https://orcid.org/0000-0001-7547-4989
Gallipoli, Paolo https://orcid.org/0000-0001-7254-2253
Funding for this research was provided by:
Cancer Research UK (C57799/A27964)
Lady Tata Memorial Trust
Article History
Received: 22 December 2023
Revised: 6 August 2024
Accepted: 15 August 2024
First Online: 26 August 2024
Competing interests
: LH is CEO and co-founder of Modulation Therapeutics, the company holding intellectual property to SSI-4. J.A.C. holds a patent regarding the use of the SCD inhibitor SSI-4.